Background illustration for clinical trials search

Paid Clinical Trials Bloomfield Hills

Discover 1,707 paid clinical trials in Bloomfield Hills, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)

for
Primary Membranous Nephropathy
Location: Detroit MI, London, Cleveland OH, Madison WI,
Sponsor: Biogen

Sex: All

Age: 18 - 70+

Code: NCT06962800

Phase3, Recruiting

Pre-Emptive LAVA-ECMO for Complex High-Risk TAVR

for
Severe Aortic Stenosis, Cardiogenic Shock,
Location: Detroit MI, Morristown NJ
Sponsor: Atlantic Health System

Sex: All

Age: 18 - 70+

Code: NCT07309029

Recruiting

The Efficacy of Tranexamic Acid in the Treatment of Lichen Planus Pigmentosus and Erythema Dyschromicum Perstans

for
Lichen Planus Pigmentosus, Erythema Dyschromicum Perstans,
Location: Detroit MI
Sponsor: Henry Ford Health System

Sex: All

Age: 18+

Code: NCT04233749

Phase2, Recruiting

Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis

for
Primary Biliary Cholangitis
Location: Detroit MI, Cleveland OH, Columbus OH, Toronto,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT06051617

Phase3, Recruiting

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

for
Triple-Negative Breast Cancer
Location: Detroit MI, Ann Arbor MI, Maumee OH, Fort Wayne IN,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06393374

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod

for
AChR-Ab Seropositive Generalized Myasthenia Gravis,
Location: Detroit MI, Columbus OH, Amherst NY, Cincinnati OH,
Sponsor: argenx

Sex: All

Age: 18+

Code: NCT07284420

Phase2, Recruiting

A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis

for
Plaque Psoriasis
Location: Detroit MI, Lorain OH, London, Mayfield Heights OH,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 12 - 17

Code: NCT06979453

Phase3, Recruiting

Optimal Timing of Routine Cervical Length Measurements During Anatomy Survey

for
Cervical Insufficiency, Preterm Birth,
Location: Detroit MI
Sponsor: Henry Ford Health System

Sex: Female

Age: 0+

Code: NCT06822647

Recruiting

Xeroderma Pigmentosum Patient Experiences

for
Xeroderma Pigmentosum
Location: Detroit MI
Sponsor: Henry Ford Health System

Sex: All

Age: 0+

Code: NCT01123694

Recruiting

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

for
Non-small Cell Lung Cancer,
Location: Detroit MI, Cleveland OH, Hamilton, Toronto, Buffalo NY,
Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

Sex: All

Age: 18+

Code: NCT06343402

Phase1, Recruiting

IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)

for
Advanced Melanoma
Location: Detroit MI, Columbus OH, Toronto, Pittsburgh PA,
Sponsor: Immunocore Ltd

Sex: All

Age: 18+

Code: NCT06112314

Phase3, Recruiting

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

for
Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis,
Location: Detroit MI, Ann Arbor MI, Cleveland OH, Independence OH,
Sponsor: Kartos Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06479135

Phase3, Recruiting

Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors

for
Solid Tumor, Adult, Metastatic Solid Tumor, Refractory Cancer,
Location: Detroit MI, Canton OH, Fairfax VA, St Louis MO
Sponsor: Sairopa B.V.

Sex: All

Age: 18+

Code: NCT05856981

Phase1, Recruiting

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

for
Melanoma
Location: Detroit MI, Ann Arbor MI, London, Cleveland OH,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06246916

Phase3, Recruiting

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

for
Locally Advanced Solid Tumor
Location: Detroit MI, Chicago IL, Zion IL, Urbana IL, Fairfax VA,
Sponsor: Tango Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05732831

Phase1, Phase2, Recruiting

A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

for
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Location: Detroit MI, Columbus OH, Toronto, Chicago IL,
Sponsor: Nuvalent Inc.

Sex: All

Age: 12+

Code: NCT05384626

Phase1, Phase2, Recruiting

A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)

for
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Location: Detroit MI, Columbus OH, Toronto, Chicago IL,
Sponsor: Nuvalent Inc.

Sex: All

Age: 12+

Code: NCT05118789

Phase1, Phase2, Recruiting

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

for
Solid Tumor, Non-Small Cell Lung Cancer, Head and Neck Cancer,
Location: Detroit MI, Louisville KY, Atlanta GA, Omaha NE,
Sponsor: Inhibrx Biosciences, Inc

Sex: All

Age: 18+

Code: NCT04198766

Phase1, Phase2, Recruiting

A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

for
Head and Neck Squamous Cell Carcinoma (HNSCC)
Location: Detroit MI, Columbus OH, Evanston IL, Edgewood KY,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06769698

Phase2, Recruiting

Study of Sacituzumab Govitecan With Atezolizumab/Durvalumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer

for
Small Cell Lung Cancer ( SCLC ),
Location: Detroit MI
Sponsor: Bindu R Potugari

Sex: All

Age: 18+

Code: NCT07339059

Phase2, Recruiting